| Epogen |
All Financial Data in US $ (mln) |
| Word Search (Top 10 - by date) |
Amgen's Second Quarter 2010 Adjusted Earnings Per Share Increased 7 Percent to $1.38
Amgen
(July 29, 2010)
|
Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
Hospira
(July 26, 2010)
|
BioVex Appoints Steven Kelly as Chief Commercial Officer
BioVex
(July 01, 2010)
|
Dennis Fenton Nominated for Election to Genzyme’s Board of Directors
Genzyme
(June 07, 2010)
|
Amgen Highlights Key Clinical Data to Be Presented at American Society of Clinical Oncology Annual Meeting
Amgen
(May 20, 2010)
|
Amgen's First Quarter 2010 Adjusted Earnings Per Share Increased 20 Percent to $1.30
Amgen
(April 21, 2010)
|
Affymax and Takeda Report Phase 2 Analyses of Hematide(TM)/peginesatide in Hemodialysis Patients
Affymax
(April 15, 2010)
|
Amgen and Centocor Ortho Biotech Products Finalize ESA Risk Evaluation and Mitigation Strategy (REMS) With FDA
Amgen
(February 16, 2010)
|
Centocor Ortho Biotech Products and Amgen Finalize ESA Risk Evaluation and Mitigation Strategy (Rems) with FDA
Johnson & Johnson
(February 16, 2010)
|
Amgen's Fourth Quarter 2009 Adjusted Earnings Per Share Decreased 1 Percent to $1.05; Full Year 2009 Adjusted Earnings Per Share Increased 8 Percent to $4.91
Amgen
(January 25, 2010)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.
|
| Summary Product Name Information |
|
|
| Product Sales Summary 2007/08 |
|
Annual Sales WW - Sales
|
Growth per Year (%)
|
|
Rank1 |
Generic Name
|
Therapeutic Subcategory
|
2007 |
2008
|
2008 |
| Epogen2 |
|
|
|
2,489 |
2,456 |
|
-1% |
|
|
Note: Shaded Cells3 |
|
|
More Product Information for EvaluatePharma® subscribersSubscribers see:
- Sales (historic and forecast to 2016 where available) listed by the reporting company or companies, including royalty, license and JV revenue where applicable
- Details of all events impacting the product
- Detailed product information, including sales forecasts listed by the reporting company or companies, indications (approved and in trial)
|
Register to access more FREE content:
- 2009 Product Sales analysis
- Download analysis into Excel
- Search 2 yrs of company press releases
|
|
|
|